Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Pharmacodynamic Models: Overview

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...

Pharmacokinetic Models: Overview

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

Pharmacokinetic Models: Comparison and Selection Criterion

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Designing and Developing Interprofessional Learning Experiences in Palliative Care: A Collaborative Workshop Approach.

Palliative medicine reports·2025

Same author

Recommendations for Specialty Palliative APRN Graduate Education.

Nurse educator·2025

Same author

Structured tailored rehabilitation after hip fragility fracture: The 'Stratify' feasibility and pilot randomised controlled trial protocol.

PloS one·2024

Same author

The United Nations' General Assembly High-Level Meeting on antimicrobial resistance: a joint statement from the Heads of Government and Chief Medical Officers of the United Kingdom's Overseas Territories.

The Journal of antimicrobial chemotherapy·2024

Same author

Investigation of COVID-19 transmission during the first community outbreak in a remote island population, Falkland Islands, April to June 2022.

PLOS global public health·2024

Same author

Let's talk early labour: The L-TEL randomised controlled trial.

Women and birth : journal of the Australian College of Midwives·2023

Same journal

AI Utilization and Clinical Judgment: Predictors of Caring Behavior Among Nursing Students.

The Journal of nursing education·2026

Same journal

Mental Health Nursing Simulation to Develop the Therapeutic Use of Self.

The Journal of nursing education·2026

Same journal

Cultivating Clinical Judgment Through Wound Building: A Teaching Innovation.

The Journal of nursing education·2026

Same journal

Pathophysiology as a Predictor of Success in a Prelicensure Undergraduate Nursing Program.

The Journal of nursing education·2026

Same journal

Perceived Faculty Support and Nursing Student Stress and Anxiety: A Systematic Review.

The Journal of nursing education·2026

Same journal

Nursing Students' Ethical Perspectives on Artificial Intelligence: Implications for Nursing Education.

The Journal of nursing education·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

Developing an interactive microsimulation method in pharmacology.

Angela S Collins¹, Barbara A Graves, Donna Gullette

¹Capstone College of Nursing, Birmingham, AL, USA. acollins@bama.ua.edu

The Journal of Nursing Education

|April 24, 2010

Summary

This summary is machine-generated.

This study introduces an interactive microsimulation for pharmacology education. It helps nursing students learn medication decision-making by showing virtual patient outcomes, reinforcing cause and effect.

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Related Experiment Videos

Last Updated: Jun 13, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Area of Science:

Medical Education
Pharmacology
Health Informatics

Background:

Clinical judgment is crucial for effective pharmacology decision-making.
Traditional education methods may not fully convey the impact of medication errors.
There is a need for safe, experiential learning tools in pharmacology.

Purpose of the Study:

To develop and evaluate an interactive microsimulation for teaching pharmacology decision-making.
To provide students with a virtual environment to practice applying drug information to patient scenarios.
To enhance understanding of the consequences of medication errors.

Main Methods:

Creation of a theory-based, interactive microsimulation with three virtual client scenarios.
Participants navigate patient situations, making clinical decisions.
Immediate visual and auditory feedback is provided based on the correctness of decisions, showing patient improvement or decompensation.

Main Results:

The microsimulation effectively demonstrates the link between clinical decisions and patient outcomes.
Students can learn from the consequences of incorrect medication choices in a risk-free virtual setting.
The tool reinforces the potential for medication errors and their sequelae.

Conclusions:

Interactive microsimulations are valuable tools for pharmacology education.
This technology facilitates learning from medication errors without patient harm.
The microsimulation can be integrated into nursing curricula to improve clinical decision-making skills.